Algeria Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria tell us why. As geographically the largest country in Africa, Algeria stands out, as does its universal healthcare system which bears…

Algeria With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect and price medicines in the future. In a fascinating interview we spoke to Rachid Kerrar from the Algerian firm Beker about their development of a cheaper, generic version of Gilead’s…

Turkey With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between the West and the East. Hakan Yurdakul, head of economy monitoring and coordination at the Presidency Office is bullish, “The…

Cancer Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one of the youngest populations in Europe, the sustainability of the system is uncertain as its incredibly young population gets older…

Algeria A confluence of factors – urbanisation, industrialisation, poor eating habits and a sedentary lifestyle – have triggered a surge in noncommunicable diseases (NCDs) in Algeria. NCDs now account for 76 percent of all deaths in the North African nation. Cardiovascular diseases are the leading individual cause of death in Algeria,…

Tunisia Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes is the second largest cause of death in Tunisia”. Moez Lindhallah Mokadem, director of Pharmacie Centrale de Tunisie (PCT), adds…

Tunisia The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th 2017 at the Tunis export centre (CEPEX) and revolved around the theme: “Sidi Thabet BioTechpole: serving innovation in the pharmaceutical…

Algeria Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and unchecked throughout the African continent to the point where they are now reaching epidemic proportions and becoming a major determinant…

Algeria In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social Security in the Ministry of Labor, Jean-Paul Digy, Vice President for…

Algeria This chart shows how Algeria’s pharmaceuticals and healthcare system has evolved over time; from the creation of the Algerian Central Pharmacy (PCA) back in 1962, all the way to the implementation of the ANPP in 2017. Click here to download the latest roundtable discussion on Algerian healthcare

Pharma As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis C epidemic, the national campaign against viral hepatitis remains Egypt’s top healthcare priority. According to Roche’s regional general manager, Ehab…

Pharma Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction and ineffectuality. The Egyptian pharmaceutical market is currently regulated by the Ministry of Health itself, with all issues related to pharmaceuticals falling under the responsibility of…